An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer We assessed cancer-related molecular marker test ...
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society ...
Tumor markers for small cell lung cancer (SCLC) are measurable using blood tests, such as neuron-specific enolase (NSE). They can support the identification and management of cancer. Doctors use a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results